Hyperfine
HYPR
Market cap $79.8M

1.03 USD

-0.04

3.74%

At close Feb 21, 4:00 PM EST

After hours

1.07

+0.04

3.88%

1 day

-3.74%

5 days

-13.45%

1 month

7.46%

3 months

5.58%

6 months

-2.83%

Year to date

5.10%

1 year

0.98%

5 years

-88.79%

10 years

-88.79%

About: Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its sales from the following sources: 1) device sales which consist of sales of MRI devices and 2) service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.

Employees: 131

Healthcare Electromedical & Electrotherapeutic Apparatus

0

Funds holding %

of 7,139 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

0.68% more ownership

Funds ownership: 17.95% [Q3] → 18.64% (+0.68%) [Q4]

8% less funds holding

Funds holding: 40 [Q3] → 37 (-3) [Q4]

15% less capital invested

Capital invested by funds: $11.2M [Q3] → $9.51M (-$1.65M) [Q4]

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for HYPR.

See Analyst Rankings

Financial journalist opinion

Hyperfine Announces $6.0 Million Registered Direct Offering

GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR--Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine” or the “Company”) today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company's Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warrant were sold together at a combined offering price of $1.33 in a registered direct offering. The warrants have an e.

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

GUILFORD, Conn.--(BUSINESS WIRE)---- $HYPR #aipowered--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis.

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

GUILFORD, Conn.--(BUSINESS WIRE)--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting.

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

GUILFORD, Conn.--(BUSINESS WIRE)--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. to present at the BTIG Digital Health Forum on November 25, 2024 and the Mizuho Healthcare Conference on December 11, 2024.

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript

Hyperfine, Inc. (NASDAQ:HYPR ) Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group Maria Sainz - President and CEO Brett Hale - Chief Administrative Officer and CFO Conference Call Participants Yuan Zhi - B. Riley Operator Good afternoon.

Hyperfine, Inc. (HYPR) Q3 2024 Earnings Call Transcript

Zacks Investment Research

Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates

Hyperfine, Inc. (HYPR) came out with a quarterly loss of $0.14 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.15 per share a year ago.

Hyperfine, Inc. (HYPR) Reports Q3 Loss, Tops Revenue Estimates

See News Rankings

Charts implemented using Lightweight Charts™